Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Neurology|July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trialRaju Kapoor, Julian Furby, Thomas Hayton, et al.Journal of Magnetic Resonance Imaging : JMRI|March 8, 2006
Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord sizeWaqar Rashid, Gerard R Davies, Declan T Chard, et al.Neurology|September 25, 2025
Effects of Phenytoin on the Retinal Ganglion Cell-Inner Plexiform Layer in Acute Optic Neuritis: Analysis of a Phase II Randomized TrialSrikirti Kodali, Alessia Bianchi, Rhian Raftopoulos, et al.Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.The Lancet. Neurology|January 30, 2016
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trialRhian Raftopoulos, Simon J Hickman, Ahmed Toosy, et al.The Lancet. Neurology|March 17, 2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extensionRaju Kapoor, Pei-Ran Ho, Nolan Campbell, et al.Pageof 2